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ABSTRACT 
Objective:  To evaluate the capacity and effectiveness of trained community pharmacists in 
delivering the Diabetes Medication Assistance Service (DMAS) via (1) number and types of 
self-management support interventions (SMSIs); (2) number of goals set and attained by 
patients and (3) patient outcomes (glycaemic control, medication adherence and satisfaction). 
Methods: Pharmacists (n=109) from 90 community pharmacies in Australia were trained and 
credentialed to deliver the DMAS. The training focused on developing pharmacists’ 
knowledge and skills in supporting patients’ diabetes self-management. 
Results:  A total of 387 patients completed the trial. The mean number of SMSIs per patient 
was 35 (SD ±31) and the majority (87%) had at least one documented goal that were fully or 
partially attained. There were significant health benefits for patients including improved 
glycaemic control and a reduced risk of non-adherence to medications. Over 90% of DMAS 
patients reported improvements in their knowledge about diabetes self-management.   
Conclusion:  
This study demonstrates the effectiveness of community pharmacists in delivering SMSIs to 
patients with T2DM.  
Practice implication: Given appropriate training in diabetes care and behavior change 
strategies, community pharmacists can offer programs which provide self-management 
support to their patients with T2DM and improve their health outcomes.  
 





Worldwide, type 2 diabetes mellitus (T2DM) has been described as a major epidemic 
which imposes a huge cost burden on families, communities and health care systems. In 
Australia, according to recent national estimates, 7.2% of the population have T2DM [1], half 
of whom have not yet been diagnosed [2].  The prevalence is expected to escalate in line with 
the continuing rise of risk factors that contribute to the development of T2DM. There is now 
conclusive evidence that intensive glycaemic control can reduce the risk and delay the onset 
of complications, and therefore improve the overall quality of life for people with T2DM [3-7].  
However, the achievement of strict glycaemic control is highly dependent on the extent to 
which an individual is able to self-manage their condition. Successful self-management of 
T2DM requires individuals to engage in various cognitive and behavioural processes on a 
daily basis to maintain blood glucose levels within the normal range, including lifestyle 
modifications, adherence to medications, self-monitoring of blood glucose (SMBG) and 
regular visits to health care professionals (HCPs). For many people with T2DM, self-
management is challenging as they do not possess adequate knowledge, skills and 
motivation to initiate and maintain behavioural changes to help them control their illness [8-
10].  
A critical strategy to address this is to educate HCPs to empower patients to be 
proactive in the self-management of their condition.  The use of motivational interviewing and 
collaborative goal setting to facilitate self-management support interventions (SMSIs) 
delivered by HCPs, has been shown to improve health outcomes for a range of chronic 
diseases including T2DM [11-15]. Motivational interviewing is a patient centered counseling 
approach designed to enhance the patient’s intrinsic motivation for behavior change [16]. It is 
based on exploring patient beliefs about perceived difficulties in changing their behavior. The 
collaborative goal setting technique involves the negotiation and setting of small, achievable 
and specific goals by patients with the assistance of their HCP to address their most pressing 
problems. Each goal is supported by a strategy designed to help the patient achieve those 
goals. The attainment of behaviour change is optimized through the patient’s personal 
investment in this process.  
The positive effects of goal setting in changing behaviour may be explained by the self-
efficacy theory [17] which suggests that successful goal attainment enhances self-efficacy by 
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motivating the patient to set and pursue future goals [18] and increases resilience when faced 
with barriers in goal pursuit [19].  The goal setting technique has been recognised by the 
American Diabetes Association to be a key component of diabetes self-management 
education programs [20].  
Community pharmacies provide easily accessible HCPs for ongoing self-management 
support of chronic conditions such as asthma [21] and T2DM [22]. However, the training of 
pharmacists in behaviour change strategies and evaluation of their application in patients with 
T2DM has not been previously reported. A recent trial, the Diabetes Pilot Program, funded by 
the Australian Government Department of Health and Ageing as part of the Fourth 
Community Pharmacy Agreement, involved the development of a training program to 
prepare pharmacists to deliver the Diabetes Medication Assistance Service (DMAS), a care 
cycle of assessment, counseling, education and review for people with T2DM, provided at 
regular intervals at the pharmacy over a 6 month period.   
The aim of this study was to evaluate (1) the impact of pharmacist training on the 
process of service delivery via the number and types of self-management support 
interventions (SMSIs) delivered by the DMAS pharmacists; (2) the impact of DMAS on patient 
self-management behaviours via the number and types of goals set and subsequently 
attained by patients and; (3) the impact of the DMAS on patients’ outcomes including mean 
blood glucose levels, medication adherence and patient satisfaction with the service. 
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2.  Methods 
 
2.1.    Ethics approval 
 
Approval for this study was granted from the Human Research Ethics Committees at 
The University of Sydney, New South Wales (NSW), Curtin University, Western Australia 
(WA), Monash University, Victoria (VIC) and The University of Tasmania, Tasmania (TAS). 
 
2.2.   Recruitment of pharmacies 
  
The recruitment of 90 community pharmacies took place during November and 
December 2007. The pharmacy eligibility criteria included having a: 
• Credentialed DMAS pharmacist  
• Process to allow an uninterrupted DMAS consultation 
• Screened counseling area or separate counseling room  
 
2.3.   Training and credentialing of the pharmacists 
 
Participating pharmacists were required to complete a 2 day competency-based, face 
to face, training workshop on delivery of the DMAS.  The first day of the workshop 
focused on developing the pharmacists’ diabetes specific skills, use of insulin pens, 
blood glucose testing devices, interpretation of SMBG and the application of 
motivational interviewing and collaborative goal setting. The second day involved an 
overview of patient education strategies and familiarization of participants with the 
study protocol and documentation. Experts in each of these areas were recruited by 
the project team and presented a mix of lectures and skills workshops to achieve the 
desired competency.  Prior to the workshop, pharmacists were required to read a 
manual which introduced the topics of pathophysiology, diagnosis, complications, co-
morbidities and pharmacotherapy of type 2 diabetes. The information in the manual 




One hundred and nine pharmacists from 90 pharmacies in metropolitan and rural 
locations across Australia (NSW, VIC, TAS, WA and Australian Capital Territory) were trained 
and credentialed to deliver the DMAS during January and February 2008. The workshops 
comprised a mix of lectures, skills sessions, case discussions and role plays. On completion, 
participants were asked to complete an evaluation questionnaire to identify participants’ 
perceptions of the training workshops.  The credentialing was based on a three 
component examination; 1) a 10 item MCQ test of diabetes knowledge, 2) a test of 
competence in using a blood glucose meter and downloading software, 3) three short 
answer case scenarios requiring interpretation of blood glucose readings. This 
examination was conducted independently by representatives from the Australian 
Association of Consultant Pharmacy (AACP), the professional accrediting body. 




2.4.    Patient recruitment and baseline assessment 
 
Each pharmacy was asked to recruit up to 10 patients and eligible patients were those 
with T2DM who had an HbA1c > 7.0, confirmed by their GP. On their first DMAS visit, patients 
were given a MediSense Optium Xceed™ blood glucose meter, instructed on its use, and 
then asked to take measurements at least once daily (preferably at different times).  During 
this visit, the pharmacist recorded each patient’s demographic details, diabetes history and 
current management, height, weight, smoking status, level of physical activity and medication 
adherence.   
 
2.5.    Pharmacist delivery of the DMAS Intervention 
 
During the next 4 DMAS visits, the pharmacists used the Precision Link Direct 
Device™ to download each patient’s blood glucose readings taken in the period since their 
last visit to generate printouts and charts of their blood glucose results which formed the basis 
of discussions between the pharmacist and the patient on areas of inadequate glycaemic 
control. The pharmacists then delivered appropriate SMSIs based on the pharmacist’s 
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assessment, taking into consideration their blood glucose readings as well as any specific 
concerns the patient had about their T2DM.  A SMSI was any action taken by a pharmacist 
during the consultation to address issues relating to SMBG, medication adherence, 
medication problems or lifestyle such as exercise, diet, foot care.  Goals to be achieved 
by the next visit were negotiated with the patient and documented on a worksheet.  At the 
final visit, the patient completed the final medication adherence assessment and a patient 
satisfaction questionnaire. A separate patient file was used by the pharmacist to 
document service delivery including clinical data, and SMSIs and patients goals 
throughout the DMAS. All patients’ files were collected at the end of the study and the 
data entered into an SPSS data base.  
 
2.6.    Evaluation of processes and outcomes 
 
The impact of DMAS was evaluated on a wide range of process and outcome 
measures (Table 1). The Brief Medication Questionnaire (BMQ) [23] is an instrument 
designed to be administered by a health professional to assess medication taking 
behavior and barriers to adherence. It consists of three scores (screens): a regimen 
screen, belief screen, and recall screen.  In all screens, a higher score indicates a higher risk 
of non-adherence. Patient satisfaction at the end of the DMAS was measured with the DDSM-
Q, a validated questionnaire of 21 items based on a 5 point Likert scale scored from 1 
(strongly disagree) through to 5 (strongly agree). It comprises 3 subscales “service”, 
“knowledge” and “self-management” [24].  
 
2.7.    Patient qualitative interviews 
 
To further investigate patient experiences with DMAS, interviews were conducted by 
telephone with a random sample, stratified by state, of 100 patients who had attended all 
5 DMAS visits. The semi structured interviews, conducted by researchers, explored six 
core issues including overall experience, patient understanding of DMAS, patient 
expectations; pharmacists’ delivery of the service; perceived need for an ongoing 





2.8.    Data analyses 
 
The data were analysed using SPSS 15.0™. Descriptive statistics were used to 
characterise the DMAS population in terms of demographics, diabetes history, clinical 
characteristics, frequency of the types of SMSIs and goals set, and the proportion of goals 
attained. To test for changes in clinical parameters over time, within each group, either paired 
Student’s t tests or Wilcoxon signed ranks test for continuous variables or the McNemar’s test 
for categorical variables were used.  The level of significance for all tests was set at p<0.05.  
 The patient interviews were tape recorded with permission, transcribed verbatim and 





3.   Results 
 
3.1.    Training evaluation 
 
Overall the training workshop was well rated by participants (Table 2) who expressed 
enthusiasm for their involvement in the DMAS and appreciated the importance of the 
credentialing for the credibility of the role. Participants reported feeling confident in being able 
to implement the DMAS in their pharmacies (median rating 2 [IQR 1-3]).  
 
3.2.    Recruitment and completion of DMAS patients 
 
Seven pharmacies withdrew prior to recruitment. The remainder (83 pharmacies) 
recruited patients between March and June 2008. A total of 998 patients agreed to 
participate but of these 474 were ineligible, i.e., without a recent HbA1c >7.  Therefore, 524 
patients were enrolled into the program (i.e., a mean of 6 [range 1-10] per pharmacy). A 
total of 387 patients (74%), (i.e., a mean of 5 [range 1-10] per pharmacy), completed all 
5 DMAS visits. The main reasons for patient withdrawal were patient relocation (6%), 
patient losing interest (5%) and pharmacist issues (7%). Pharmacist issues included 
pharmacist illness, employee pharmacist relocation and maternity leave.  
 
3.3.    Patient demographics and diabetes history at baseline 
 
The mean age for the entire cohort was 63 years with similar proportions of males and 
females (Table 3). On average, patients had had diabetes for 10 years with the most 
commonly self-reported diabetes co-morbidities being high blood pressure and high 
cholesterol (Table 3). At baseline, the majority of patients reported being treated with oral 




3.4.    Self-management support interventions (SMSI) delivered by the pharmacists 
 
A total of 18,144 SMSIs were delivered by the pharmacists to patients during the 
DMAS consultations. The mean number of SMSIs per patient was 35 (SD ±31). DMAS 
patients received SMSIs relating to medication adherence (83%), medication use problems 
(51%), SMBG (80%) and lifestyle (77%) (Figure 1). SMSIs relating to medication adherence 
included education about medications, ability to access medications and insulin administration 
and were received by 83%, 55% and 47% of patients, respectively.  SMSIs relating to 
medication use problems included drug or dose discrepancies, potential therapeutic 
problems, and “other” problems and were received by 46%, 42% and 44% of patients, 
respectively.  SMSIs relating to SMBG included technique, hypoglycaemia and 
hyperglycaemia and were received by 80%, 65% and 72% of patients, respectively.  Lifestyle 
SMSIs included physical activity and nutrition advice being received by more than 70% of 
patients; smoking and alcohol SMSIs by 37% of patients; and foot care SMSIs by 65% of 
patients. 
 
3.5.    Total number of documented goals 
 
The records for completed patients (n=387) were further evaluated to establish the 
number and types of goals set and attained. Of these, 347 (90%) had at least one 
documented goal in the patient file. The most common type of goal was physical activity 
(26%). This was followed by diet (23%), SMBG (15%) and the “other” category (8%) which 
comprised foot care, insulin dosage adjustment, blood pressure control and complications 
monitoring.  One-third of the goals were attained while a greater proportion of goals were 
partially attained (53%). In contrast, only 14% of goals were not attained to any degree.  
 
3.6.    Baseline and final measures of the DMAS intervention 
 
There was a significant reduction in the mean blood glucose levels (BGL) of patients 
from 9.5 (±4.4) mmol/L to 8.7 (±2.1) mmol/L over the 6 months of the DMAS (t=3.5;df 
385;p<0.001). The proportion of BGL readings outside range fell from 59% (±26%) to 
52% (±26%) (t=4.8;df 385;p<0.001). In the BMQ adherence screens, patients showed a 
10 
 
significant reduction in mean regimen, belief and total screen scores indicating a reduction in 
the risk of non-adherence to medication (Table 5).  In terms of individual items making up the 
BMQ screens, there were reductions in the proportion of patients who reported stopping or 
interrupting therapy due to a late refill (from 9.7% to 7.5%); taking less than the prescribed 
amount (from 13.3% to 10.0%); taking more than the prescribed amount (from 3% to 1.4%); 
or missing doses (from 22.4% to 18.7%). The proportion of patients who smoked decreased 
and, in addition, there was an increase in the proportion of patients who exercised three or 
more times per week, but these improvements were not statistically significant. There was no 
significant change in the proportion of patients exercising more than five times per week nor 
was there any change in BMI. 
 
3.7.    Patient satisfaction  
 
A total of 323 patients completed the DDSM-Q at the end of the DMAS and the results 
showed that patients were highly satisfied with the “service” perspective of DMAS, which was 
centered on the delivery of the service by the pharmacist. The results of the sub-scales 
relating to patient satisfaction on “knowledge” and “self-management” of their diabetes are 
shown in Tables 6 and 7, respectively. Almost all respondents agreed with the statements “I 
am satisfied with my understanding of when I should check my blood sugar levels” and that 
“the service gave me confidence to deal with my diabetes”.  
 
3.8.    Patient Interviews 
 
A number of distinct themes were identified. The majority of patients reported 
improvements in monitoring of their diabetes, medication adherence, lifestyle management 
and understanding of diabetes and its complications. Patients who were newly diagnosed with 
diabetes reported that they gained a lot of knowledge from the DMAS. In contrast, patients 
who had had diabetes for a number of years reported that while the DMAS did not necessarily 
increase their knowledge on diabetes, it increased their motivation to improve the 





3.8.1.   Impact on knowledge of SMBG 
 
Patients reported that improved SMBG supported by the printouts and discussions 
during the DMAS visit increased their awareness about their blood glucose levels. 
 “Monitoring twice a day…my blood test came down to 8 - 9 from 12 – 13.”  (Patient 16, 
NSW) 
 “Loved the charts as I could see myself improving each time.”  (Patient 4, WA) 
 
3.8.2.   Impact on knowledge of medications 
 
In general patients reported improvements in understanding of diabetes medications 
and those on insulin therapy were better able to manage insulin dosing using the SMGB 
results.  
 “I learned that I was taking my medications incorrectly…should have been taking them 
before meals and I had been taking them after meals.”  (Patient 16, NSW) 
 “Working out the balance between insulin and food intake ……and alter the units as 
needed. I tend to get hypos between midnight and 1am so need to control insulin 
amount in evenings.”  (Patient 2, WA) 
 
3.8.3.   Impact on knowledge of lifestyle  
 
Patients reported that the pharmacist educated them about appropriate diet, exercise, 
alcohol and smoking and advised how improvements in lifestyle management played an 
important role in improving glycaemic control. In many cases, pharmacists referred patients to 
a dietician and the patient brought the dietician’s report to subsequent DMAS visits for 
discussion with the pharmacist.  
 “It was fantastic because I had no control over my diabetes. I lost weight (14 kilos).”  
(Patient 17, NSW) 
 “I have cut down on the number of cigarettes I smoke every day and only drink once a 
week now. More exercise and less cigarettes.”  (Patient 12, NSW) 
“I learnt a hell of a lot…..I have a better understanding of the effects of alcohol and 
exercise on my blood sugars.”  (Patient 18, NSW) 
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4.    Discussion 
 
4.1.    Discussion 
 
The DMAS training workshops were well received by the pharmacists who expressed 
confidence in engaging their patients in diabetes self-management support and education. 
Importantly, pharmacists reported that the training workshops had enabled them to apply their 
diabetes knowledge and skills during the DMAS trial.   
Most patients received SMSIs from the DMAS pharmacists relating to medication 
adherence, SMBG and lifestyle while 50% received SMSIs relating to medication use 
problems.  The high frequency of SMSIs per patient over the 6 months DMAS reflects the 
complexity of diabetes self-management which involves adherence to diet, physical activity, 
medication and SMBG. A single visit would not allow for adequate coverage of all aspects of 
self-management relevant to the individual and highlights the need for repeated contacts with 
HCPs in the process of chronic care [25].  
The importance of review and monitoring of goals to support behavior change by 
patients was also underscored by the need to reset goals that had only been partially met at 
follow up visits which suggests that behavior change takes time. Goal setting is a process 
whereby the patient is often required to learn and master an entirely new cognitive skill (ie. 
problem identification, setting attainable and realistic goals), while at the same time to 
develop mastery over changing entrenched habits. In particular, lifestyle factors such as 
losing weight or giving up smoking are not achievable within a short time-frame. To maintain 
patients’ motivation for behavior change and maximize the likelihood of successfully attaining 
these goals, external sources of regular support and positive reinforcement from health 
professionals is critical [26-28].   
The patient processes evaluated during the DMAS showed that most patients had a 
least one documented goal and the most common of these related to lifestyle or SMBG. 
There were very few goals set in relation to medications which may indicate a lack of patient 
“readiness” to set a specific goal that is relevant to them about their medications. The greater 
willingness of patients to set goals around lifestyle indicates that when patients are given 
choice in self-management of their chronic condition they are likely to focus on those aspects 
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of self-management which are of most personal importance or relevance to them [21, 29]. 
The essence of successful goal attainment is personal investment and the degree of 
perceived controllability an individual has over an event [28, 30, 31]. In the context of the 
current study, lifestyle changes may be viewed as more personally controllable than changes 
to medication regimens. 
At the end of the DMAS, achievement of goals was reflected in the improved patient 
health outcomes. This indicates that the pharmacists could provide effective SMSIs to foster 
lifestyle changes to achieve glycaemic control and reduce the risk of complications [32]. 
Furthermore, the level of goals which were attained suggests that the necessary skills, 
knowledge and motivation to drive behavior change strategies were acquired by patients 
during the DMAS. 
Approximately one third of this patient cohort at baseline had not received any prior 
diabetes education. The reasons for this were not recorded but the willingness of these 
patients to participate in a community pharmacy diabetes education program may suggest a 
lack of other education programs for T2DM in the local area, or an increased 
convenience/accessibility of attending an education program at their local pharmacy.  This 
was highlighted by the high level of patient satisfaction with the pharmacists’ delivery of the 
DMAS as well as the environment and convenience of the pharmacy. There was strong 
support for continued availability of the DMAS in their local community pharmacy.  
After the trial, a majority of DMAS patients reported having increased knowledge and 
motivation with respect to diabetes self-management. This was reflected in significant 
improvements in medication adherence scores and a significant reduction in mean blood 
glucose levels during the DMAS. The clinical effectiveness of the DMAS has been reported 
previously and included significant reductions in HbA1c, blood pressure, total cholesterol and 
triglycerides [22]. Patients reported that they liked the pie charts and graphs printed by the 
pharmacist during the visits. The patient often brought a copy to a subsequent visit to the GP 
or specialist. The effectiveness of community based SMSIs delivered by trained HCPs 
immediately prior to a visit to the GP has been shown to empower patients to take a more 
pro-active approach in their interactions with their GP [33]. Patients who were newly 
diagnosed found the DMAS extremely useful as they had no previous understanding of 
diabetes or its complications. These individuals reported very significant improvements in 
lifestyle which is typically recommended for those newly diagnosed with T2DM [32]. 
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Furthermore, patients who were on insulin improved their ability to monitor and make 
adjustments to their insulin dose in response to blood glucose readings and changes in 
physical activity and food intake. 
There were some limitations to this study. Firstly it did not include a control 
group, so we cannot be certain that the changes in outcomes were due to the 
pharmacist intervention alone. However the DMAS was previously tested in an RCT 
and shown to be clinically effective [22]. Much of the data, including adherence, goal 
setting and pharmacist interventions, were self-reported and therefore, may be subject to 
bias. To address this limitation, further improvements to the patient file documentation would 
be required in the future to optimize the recording of goal setting and pharmacist SMSIs.  
 
4.2.    Conclusion 
 
Community pharmacies are a valuable and underutilized resource for the disease 
management of T2DM. The results of this study suggest that appropriately trained 
pharmacists can deliver effective self-management support to patients with T2DM in 
the community setting. The most useful component of the DMAS was the pharmacists’ 
support of SMBG as a tool to help the patient effectively self-manage aspects of their 
diabetes, including food intake, exercise and correct medication use. Other benefits of DMAS 
included improved understanding of diabetes and its management and increased motivation 
to lose weight and exercise regularly. The DMAS service resulted in improved clinical 
outcomes and was highly valued by patients, based both on the findings of the interviews 
and the patients’ satisfaction questionnaires. Given that the DMAS was implemented in 83 
pharmacies of differing sizes located in 5 states across Australia in rural and 
metropolitan communities suggests that the model may be generalisable. 
 
4.3.   Practice Implications 
 
This study supports the feasibility and effectiveness of community pharmacists in 
supporting self-management behaviors of patients with T2DM. Based on evidence from large 
clinical trials [22], the extent of improvement in diabetes control achieved by the DMAS will 
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Number of self-management support interventions 
(SMSIs) delivered by the pharmacists 
Number of goals set by the patients  
Number of goals attained by the patients 
 
Mean blood glucose levels at each DMAS visit 
Medication adherence (BMQ) 
Body mass index  (BMI) 
Physical activity 
Smoking status 






Table 2: Pharmacists’ evaluation of the  
DMAS training workshop (n=109) 
 




Expectation of the workshop 




Relevance of the workshop 
(“1” relevant to “7” irrelevant) 
1 
(1-2) 
Amount of information  

























Table 3: Demographic characteristics of DMAS patients at baseline (n=524)  
 Mean SD 
Age (years)  62.8 11.1 
    
  N % 
Gender    
 Male 278 53 
 Female 243 46 
 Missing 3 1 
    
Country of birth    
 Australia  353 67 
 Other  163 31 
 Missing 8 2 
    
Reside    
 Alone  109 21 
 With someone 408 78 
 Missing 7 1 
    
Education past minimum 
school-leaving age    
 Yes 184 35 
 No 332 63 
 Missing 8 2 
    
Employment status 
   
 Retired 275 52 
 Employed  141 27 
 Un-employed 104 20 
 Missing 4 1 
    
Receive pension 
   
 Yes 328 63 
 No 191 36 
 Missing 5 1 
    
23 
 
Table 4: Diabetes history of DMAS patients at baseline (n=524) 
 Mean SD 
Years since diagnosis 10.2 7.6 
 
  N % 
Current Management 
 No Medications 2 1 
 Oral hypoglycaemics only 360 69 
 Insulin only 16 3 
 Insulin & oral 
hypoglycaemics 134 25 
 
Missing 12 2 
 
Prior Diabetes Education 
 Yes 320 61 
 No  192 37 
 Missing 12 2 
 
Monitoring blood glucose at home 
 Yes 461 88 
 No 59 11 
 Missing 4 1 
 
Self-reported history of diabetes complications and co-morbidities 
 High blood pressure 369 70 
 Stroke 36 7 
 Angina 102 19 
 Heart attack 59 11 
 High cholesterol 311 59 
 Eye problems 128 24 
 Kidney problems 62 12 








Table 5: Medication adherence scores for DMAS participants at baseline and final visits  
Brief Medication Questionnaire (BMQ)  
 n Baseline mean (CI) Final mean (CI) Baseline versus final p value 
Regimen screen # 
(range 0-8) 
346 1.2 (1.08-1.34) 0.84 (0.73-0.95) <0.001 
Belief screen * 
(range 0-2) 
345 0.62 (0.54-0.70) 0.37 (0.3-0.44) <0.0001 
Recall screen  
(range 0-2)˜˜ 
347 0.98 (0.92-1.04) 1.00 (0.93-1.06) 0.58 
Total score 
(range 0-12) 
338 2.80 (2.61-3.00) 2.20 (2.03-2.38) <0.0001 
#Regimen screen - measures whether the patient knows the names, the purpose of all their medication(s) and how the patient has 
taken their medication(s) over the past 7 days  
*Belief screen - measures whether patient believes the medication(s) are working and if they have experienced any problems with 
any medication  
˜˜ Recall screen – measures any problems the patients have  with taking their medication(s) eg remembering, collecting refills, 





Table 6: DDSMQ - Patient Satisfaction on Knowledge (n= 323) 
 Degree of Satisfaction* 
I am satisfied with my understanding of when I should check 
my blood sugar levels 
97% strongly agree or agree 
I am satisfied with my understanding of how things can 
change my blood sugar levels because of diabetes 
91% strongly agree or agree 
I am satisfied with my understanding of what I should eat to 
control my diabetes 
93% strongly agree or agree 
I am satisfied with my understanding of the types and 
amounts of physical activity I can do to control my diabetes 
92% strongly agree or agree 
I do not know what types of exercise are beneficial to control 
my diabetes  
73% strongly disagree or 
disagree 
* For each item responses on the 5 point Likert scale were recoded into 3 categories and the highest proportion of responses 






Table 7: DDSMQ - Patient Satisfaction on Self-Management (n=323) 
 
 
* For each item responses on the 5 point Likert scale were recoded into 3 categories and the highest proportion of responses 
is presented in the table 
 
  
 Degree of Satisfaction 
The service gave me confidence to deal with my diabetes 89% strongly agree or agree 
I am more compliant with my medications since participating 
in the service 
81% strongly agree or agree 
I have improved my lifestyle since participating in the service 76% strongly agree or agree 
I feel a sense of accomplishment after achievement of my 
goals and participating in the service 
83% strongly agree or agree 
The service motivated me to stay in control of my diabetes 84% strongly agree or agree 
I monitor my blood glucose levels before meals and at 
bedtime on different days of the week since participating in 
the service   








*Includes completed and non-completed patients 
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